Monoclonal antibody therapy for lymphoma
โ
Peter Campbell; Robert Marcus
๐
Article
๐
2003
๐
Elsevier Science
๐
English
โ 139 KB
Monoclonal antibodies are an exciting advance in the treatment of lymphoma. They are safe and well-tolerated, and exhibit little cross-resistance with conventional chemotherapeutic agents. In indolent lymphomas, antibody therapy has shown useful response rates, both as first-line therapy and in rela